Publications by authors named "Manuel Nava"

Claim this Profile
I
Immunology of Hypertension: Pathophysiological and Therapeutic Aspects.
Alexander Manzano, Heliana Parra, Daniela Ariza, Maria Marquina, Pablo Duran, Manuel Nava

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Mervin Chávez-Castillo, María Paula Gotera, Pablo Duran, María P Díaz, Manuel Nava

Molecules· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic and Hepatic Injury in COVID-19: A Worse Prognosis in NAFLD Patients?
Edgardo Mengual-Moreno, Manuel Nava, Alexander Manzano, Daniela Ariza, Luis D'Marco

Biomedicines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation.
Luis D'Marco, Ana Checa-Ros, Dionilux Gamero, Carlos Soto, Juan Salazar, Manuel Nava

Healthcare (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Newly Diagnosed Hypertension and Polypharmacy with Frailty in a Tertiary Hospital Patients from Maracaibo City, Venezuela.
Juan Salazar, Isabel Borges, Alejandra Rivas-Motenegro, Nelson Villasmil-Hernandez, Manuel Nava

Curr Hypertens Rev· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy.
Ángel Ortega, Juan Salazar, Néstor Galban, Milagros Rojas, Daniela Ariza, Manuel Nava

Int J Mol Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence.
Luis D'Marco, Valery Morillo, José Luis Gorriz, María K Suarez, Manuel Nava

J Diabetes Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.
Juan Salazar, Daniela Pirela, Manuel Nava, Ana Castro, Lissé Angarita

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium.
Valmore Bermúdez, Pablo Durán, Edward Rojas, María P Díaz, José Rivas, Manuel Nava

Front Endocrinol (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela.
Valmore Bermúdez, Juan Salazar, Jorge Fuenmayor, Manuel Nava, Ángel Ortega

J Obes· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror.
María Sofía Martínez, Alexander Manzano, Luis Carlos Olivar, Manuel Nava, Juan Salazar

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease.
Mervin Chávez-Castillo, Manuel Nava, Ángel Ortega, Milagros Rojas, Victoria Núñez

Curr Neuropharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Glycation End Products: New Clinical and Molecular Perspectives.
Juan Salazar, Carla Navarro, Ángel Ortega, Manuel Nava, Daniela Morillo

Int J Environ Res Public Health· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links.
Milagros Rojas, Mervin Chávez-Castillo, Jordan Bautista, Ángel Ortega, Manuel Nava

World J Diabetes· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-specific waist circumference cutoff-points for abdominal obesity diagnosis: a personalized strategy for a large Venezuelan population.
Valmore Bermudez, Juan Salazar, María Sofía Martínez, Luis Carlos Olivar, Manuel Nava

J Diabetes Metab Disord· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Syndrome: Is It Time to Add the Central Nervous System?
Milagros Rojas, Mervin Chávez-Castillo, Daniela Pirela, Heliana Parra, Manuel Nava

Nutrients· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Aging Effect of Metformin: A Molecular and Therapeutical Perspective.
Wheeler Torres, Manuel Nava, Nestor Galbán, Yosselin Gómez, Valery Morillo

Curr Pharm Des· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-epidemiological analysis of HDL2 and HDL3 subfractions in adults from Maracaibo city, Venezuela.
Sergia Linares, Valmore Bermúdez, Juan Salazar, Manuel Nava, Ángel Ortega

Rev Peru Med Exp Salud Publica· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is "Leptin Resistance" Another Key Resistance to Manage Type 2 Diabetes?
Juan Salazar, Mervin Chávez-Castillo, Joselyn Rojas, Angel Ortega, Manuel Nava

Curr Diabetes Rev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.
Mervin Chávez-Castillo, Victoria Núñez, Manuel Nava, Ángel Ortega, Milagros Rojas

Adv Pharmacol Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy.
Joselyn Rojas, Valmore Bermudez, Jim Palmar, María Sofía Martínez, Luis Carlos Olivar, Manuel Nava

J Diabetes Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis